Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Radiation therapy for prostatic cancer].

T Teshima1, M Chatani, T Inoue

  • 1Department of Radiation Therapy, Center for Adult Diseases, Osaka.

Nihon Gan Chiryo Gakkai Shi
|July 20, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence, incidence and persistence of ADHD drug use in Japan.

Epidemiology and psychiatric sciences·2018
Same author

Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.

Translational psychiatry·2017
Same author

Do teas rich in antioxidants reduce the physicochemical and peroxidative risk factors for calcium oxalate nephrolithiasis in humans? Pilot studies with Rooibos herbal tea and Japanese green tea.

Urolithiasis·2016
Same author

Efficacy of the Mirasol pathogen reduction technology system against severe fever with thrombocytopenia syndrome virus (SFTSV).

Vox sanguinis·2015
Same author

Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.

International journal of urology : official journal of the Japanese Urological Association·2013
Same author

Parallel comparison of apheresis-collected platelet concentrates stored in four different additive solutions.

Vox sanguinis·2013

Radiation therapy for prostate cancer shows improved survival for early stages (C or less) compared to advanced Stage D. Optimal radiation doses and field sizes were identified to balance local control and complications.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Context:

  • Prostate cancer treatment
  • Radiation therapy techniques
  • Clinical outcomes analysis

Purpose:

  • To evaluate the efficacy and safety of radiation therapy for prostate adenocarcinoma.
  • To determine optimal radiation doses and field sizes for prostate cancer treatment.
  • To analyze survival rates and rectal complications in relation to disease stage.

Summary:

  • A study of 26 prostate adenocarcinoma patients treated with radiation therapy from 1979-1988 revealed a 5-year survival rate of 59% for Stages C or less versus 10% for Stage D (p < 0.007).
  • Optimal radiation doses ranged from 64.8 Gy to 68.4 Gy (TDF 100-106) for balancing local control and complications.

Related Experiment Videos

  • Optimum boost radiation field size was determined to be 30-48 cm² using a rotation technique after whole pelvic irradiation.

    • Impact:

    • Establishes evidence-based recommendations for radiation dosing and field sizing in prostate cancer management.
    • Provides insights into long-term survival outcomes for different stages of prostate adenocarcinoma treated with radiation.
    • Contributes to understanding the risk-benefit profile of radiation therapy, including rectal injury rates.